Episode 4, featuring Dr Sheila Martins
Host Dr Eva Rocha Ramos interviews Dr Sheila Martins, president of the World Stroke Organization, professor of Neurology at the Federal University of Rio Grande do Sul, head of Neurology and Neurosurgery at Moinhos de Vento Hospital and founder and president of the Brazilian Stroke Network. Dr Martins discusses her work to improve the lives of patients with stroke both regionally and globally, and her journey to becoming the first female, Brazilian, and Latin American president of the World Stroke Organization.
22 Elo 202318min
Episode 3, featuring Dr Sunil A. Sheth
Host Eva Rocha Ramos interviews Dr Sunil A. Sheth from McGovern Medical School at UT Health Houston about his recent article in JAHA, “Women with Large Vessel Occlusion Acute Ischemic Stroke Are Less Likely to Be Routed to Comprehensive Stroke Centers.” Dr Sheth discusses the importance of addressing disparities in pre-hospital routing and avoiding gender biases in clinical practice, as well as his advice to trainees pursuing a career as a vascular and interventional neurologist. For the full article: https://www.ahajournals.org/doi/10.1161/JAHA.123.029830
21 Heinä 202313min
Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity
Host Laxmi Mehta interviews Dr. Erin Michos from Johns Hopkins University about her review article “Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity.” Dr. Michos discusses how prescribing GLP-1 receptor agonists to treat obesity can help preventive cardiologists reduce their patients’ overall cardiovascular risk, and how engaging in self-care can help clinicians achieve better outcomes for their patients. For the full article: Click here
6 Kesä 202320min
AHA! With JAHA
Hosts Laxmi Mehta and Eva Rocha interview Dr. Brian Olshansky from the University of Iowa about his study "Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT," his path to becoming a renowned electrophysiologist, and his advice to trainees working toward a fulfilling career in medicine. Read Dr. Olshansky’s study
2 Touko 202314min
